Contact Us

    Your data will be processed by MYSPHERA, S.L., in order to manage your question or doubt, in the same way your data may be treated for historical or statistical purposes. Your data is processed based on the consent given by sending this form. Your personal data will not be transferred to third parties, except for the cases provided for in current legislation. Users whose data are subject to processing may exercise their rightsof access, rectification, deletion, limitation, portability or, where appropriate, opposition of their data, in the terms specified in the General Regulation of Protection of Personal Data,according to the legally established procedure. These rights may be exercised by directing written communication, duly signed, accompanied by a photocopy of the DNI, to MYSPHERA, SL, Ronda Auguste and Louis Lumiere 23, Nave 13, Paterna (Valencia) or through the email address gdpr @ mysphera. com . The data of the users whose data are processed, may be retained while they do not exercise the rights of suppression or opposition. Also, in the event that your right to the protection of personal data is violated, you may file a complaint with the Spanish Agency for Data Protection (

    MYSPHERA raises 7.6M of EU funding

    Our solutions for the automation of patient flow have caught the attention of the European Innovation Council and the SMEs Executive Agency (EISMEA), making us one of the eleven Spanish companies selected to receive one of the largest funding operations in history of the European Union (627 million distributed to a total of 99 companies).


    After such a difficult 2020 and 2021 for the healthcare sector, the effort and tenacity of our team have been rewarded by the European Innovation Council through one of the largest funding rounds to date. 7.6 million euros that serve not only as recognition of our track record but also as a definitive boost to continue growing and scaling our solutions globally.


    The selection of the 99 companies, among which MYSPHERA is included, has been made after a rigorous process, introduced under Horizon Europe, in which a group of external experts has evaluated each of the projects and a jury of experienced investors and entrepreneurs have interviewed each finalist in the process.


    Source: Source: European Innovation Council Accelerator


    In our case, the project presented arose from one of the biggest challenges currently facing the healthcare system, the constant growth of waiting lists in Europe. In addition to fighting the pandemic, hospitals must reach maximum care capacity in order to return to normality.


    On the other hand, COVID-19 has uncovered another major challenge: the lack of awareness of the real value of technology. Specialized companies such as MYSPHERA invest a lot of time and effort in developing solutions to deal with delays in healthcare, as well as to create new healthcare flows when care needs to be improved or when a large healthcare demand has to be met with a limited budget.


    It is therefore vital that all this work and effort reaches hospitals by providing them with seamless and agile care flows, as well as the means to plan activity quickly while optimizing resources and healthcare capacity to the maximum. All this, not only in a single department but throughout the patient’s entire journey through the various clinical areas (emergency, surgery, ICU, outpatient, etc.).


    Faced with these two complex problems, we presented our patient flow automation solution to the European Commission, which is capable of completely changing the rules of the game by allowing:


    – Track and manage the patient journey in real-time.
    – Automate the surgical process through adapted applications that allow staff to have live data and notifications on patient flow.


    Currently, the deployment of this solution requires several months of co-design work with the hospital, which limits its potential for scalability. However, our goal is to reduce the effort and time from months to just a few days.


    A goal that has undoubtedly caught the attention of the European Innovation Council and the SMEs Executive Agency (EISMEA) and has earned us this recognition in the form of funding that we hope will be the definitive push to transform the healthcare system in a global level.

    By: Mireya Lázaro